For this bonus episode of Healthy Maine Talks, Matt sits down with Barry Chaffin, co-founder and managing partner of Nova Analytic Labs, one of a handful of certified, licensed cannabis testing facilities in Maine.
Barry and Matt discuss the lack of sufficient testing and oversight in Maine's medical cannabis program and how it puts consumers at risk. Nova Analytic Labs recently conducted its own testing of medical cannabis products, and found that 20.73% of the samples tested failed for pesticide contamination.
Despite the lack of adequate testing, Maine's legislators are considering policy changes that would weaken oversight of the medical cannabis program even further.
For this bonus episode of Healthy Maine Talks, Matt sits down with Barry Chaffin, co-founder and managing partner of Nova Analytic Labs, one of a handful of certified, licensed cannabis testing facilities in Maine.
Barry and Matt discuss the lack of sufficient testing and oversight in Maine's medical cannabis program and how it puts consumers at risk. Nova Analytic Labs recently conducted its own testing of medical cannabis products, and found that 20.73% of the samples tested failed for pesticide contamination.
Despite the lack of adequate testing, Maine's legislators are considering policy changes that would weaken oversight of the medical cannabis program even further.